Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

The emerging nanomedicine landscape

Nature Biotechnology volume 24, pages 1211–1217 (2006)Cite this article

A global survey of companies pursuing 'nanomedicine' indicates that nanotechnology is taking root in the drug and medical device industry.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Nanomedicine publications and patents worldwide.
Figure 2: Sectorial and country breakdown of nanomedicine publications.
Figure 3: Sectorial and country breakdown of nanomedicine patent filings worldwide.

References

  1. European Science Foundation. Nanomedicine. An ESF–European Medical Research Councils (EMRC) Forward Look Report. (European Science Foundation, Strasbourg, 2005).

  2. European Science and Technology Observatory. Nanobiotechnology in the Medical Sector – Drivers for Development and Possible Impacts (Institute for Prospective Technological Studies, October 2006).

  3. Duncan, R. Nanomedicines in action. Pharm. J. 273, 485–488 (2004).

    Google Scholar 

  4. Royal Society & Royal Academy of Engineering. Nanoscience and Nanotechnologies: Opportunities and Uncertainties (Royal Society, London, 2004).

  5. Sato, M. & Webster, T.J. Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications. Expert Rev. Med. Devices 1, 105–114 (2004).

    Article  CAS  Google Scholar 

  6. European Commission. Nanosciences and Nanotechnologies: An Action Plan for Europe 2005–2009 COM (European Commission, Brussels, 2005). http://cordis.europa.eu/nanotechnology/actionplan.

  7. Allen, T.M. & Cullis, P.R. Drug delivery systems: entering the mainstream. Science 303, 1818–1822 (2004).

    Article  CAS  Google Scholar 

  8. Duncan, R. Polymer therapeutics into the 21st Century, in Controlled Drug Delivery. ACS Symposium Series, vol. 752 (eds. Park, K. & Mrsny, R.J.) 350–363 (American Chemical Society, Washington, DC, 2000).

    Book  Google Scholar 

  9. Maurer, N., Fenske, D.B. & Cullis P.R. Developments in liposomal drug delivery systems. Expert Opin. Biol. Ther. 1, 923–947 (2001).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Data presented were largely derived from the European Science and Technology Observation network (ESTO) study Nanobiotechnology in the Medical Sector—Drivers for Development and Possible Impacts funded by the European Commission through ESTO. We are grateful to our anonymous interviewees who all gave generously of their time. We thank Yves Verbandt at the European Patent Office for the extensive analysis of the nanomedicine patent data. Thanks also to Jascha Knoche for preparing the figures.

Author information

Authors and Affiliations

  1. VDI Technologiezentrum GmbH, The Association of German Engineers, Graf-Recke-Strasse 84, Düsseldorf, 40239, Germany

    Volker Wagner & Axel Zweck

  2. European Patent Office, Patentlaan 2, 2288 EE Rijswijk, The Netherlands

    Anwyn Dullaart

  3. European Commission, Joint Research Centre, Institute for Prospective Technological Studies, Edificio Expo, Inca Garcilaso, Seville, E-41092, Spain

    Anne-Katrin Bock

Authors
  1. Volker Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anwyn Dullaart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne-Katrin Bock
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Axel Zweck
    View author publications

    You can also search for this author in PubMed Google Scholar

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner, V., Dullaart, A., Bock, AK. et al. The emerging nanomedicine landscape. Nat Biotechnol 24, 1211–1217 (2006). https://doi.org/10.1038/nbt1006-1211

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1006-1211

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing